Skip to main content
ConductScienceScienceDex

Carlos Castro-gonzalez

FY2026 NIH rank #19,163
Unclaimed recordClaim profile
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 14214689Search this ID in NIH RePORTER
ORCID iD
https://orcid.org/0000-0002-3483-6661Verified identifier for this researcher
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2026

Linked Award Amount
$991.9K
Full award amounts, FY2026
Award Records
1
Records listing this PI
Award-Linked Rank
#19,163
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Carlos Castro-gonzalez. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

NCI

National Cancer Institute

$991.9K

1 awards · administering

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Carlos Castro-gonzalez as a PI. Multi-PI records show the full award amount for context.

  • 5R44CA228920-06R44
    Reducing the incidence of febrile neutropenia in cancer patients treated with chemotherapy with PointCheck: a portable non-invasive neutropenia analyzer
    Leuko Labs, Inc.
    $991.9K
    award amount

Award organization

Organizations that administered FY2026 awards listing Carlos Castro-gonzalez as a PI.

FY2026 award administered by Leuko Labs, Inc. (MA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Leuko Labs, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #7103
  5. 2025
    $2M Cumulative Funding

Explore further

Find collaborators for Carlos Castro-gonzalez

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →